Skip to main content
Premium Trial:

Request an Annual Quote

GeneFormatics Taps IBM to Help Develop Proteomic Program (IBM s Sugar Helped)

NEW YORK, Dec. 18 — IBM will become the preferred technology partner for structural proteomics firm GeneFormatics, the companies said on Tuesday.


According to the agreement, the computer giant will provide hardware, software, and services to support GeneFormatics, and has staked a claim in the company's third round of equity financing, originally announced in October.


Financial details of the deal, including IBM's equity investment, were not disclosed.


GeneFormatics' core business is a proprietary "function first" approach to protein analysis, an effort designed to determine protein function prior to high-resolution 3-D structure analysis. GeneFormatics is betting that IBM's IT technology will help it develop this process.


The system IBM will provide will include a group of Linux-based eServer xSeries 330 systems, its Enterprise Storage Server, and a DB2 Universal database. GeneFormatics also plans to add IBM's DiscoveryLink data integration software to help organize and synthesize proteomic information.


GeneFormatics, headquartered in San Diego, Calif., had raised $22 million in its third round of financing.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.